A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy

Clinical trial NCT06654440 · RECRUITING

Trial details

NCT number: NCT06654440
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Gynecological Malignancy

Start date: 2024-11-15
Primary completion: 2025-08-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.